http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2522908-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee381bc828d34401bc6804e07dac95f5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6949 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08293d0c714525f0bc60df5442ba6806 |
| publicationDate | 2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2522908-T3 |
| titleOfInvention | Compositions based on polycyclic bridged compounds for disease inhibition and relief |
| abstract | A chemical composition comprising: a chemical compound, in which the chemical compound comprises a general structure (Ia) or (I): in which each R1 is independently an alkyl-aryl group, an alkyl-aryl group substituted, an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, N, N + H N + R3, a heterocycle group, or a substituted heterocycle group; wherein each R2 is independently an alkyl-aryl group, a substituted alkyl-aryl group, an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group or a substituted heterocycle group , a covalent bond, or an alkene; wherein each R3 is independently hydrogen, a pharmaceutically active agent, an alkyl-aryl group, a substituted alkyl-aryl group, an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group, a substituted heterocycle group, an alkene, an ether, a guanidine moiety, a PEG, a PEI, or any combination thereof, where at least two R3 are pharmaceutically active agents, and where the pharmaceutically active agent is configured to inhibit and / or alleviate at least one medical condition; wherein each R4 is independently an alkyl-aryl group, a substituted alkyl-aryl group, an alkyl group, a substituted alkyl group, an aryl group, a substituted aryl group, a heterocycle group or a substituted heterocycle group , an ether, an amide, an alcohol, an ester, a sulfonamide, a sulfanilamide or an alkene; wherein Z comprises at least one bridge, where at least one of the bridges is - R2-N + R3 2-R4-N + R3 2-R2-, -R2-NR3-R4-N + R3 2-R2- , -R2-NR3-R4-NR3-R2- or -R2-N> = R4> = N-R2-, and where each bridge independently couples R1 to R1; and in which X comprises at least one counterion. |
| priorityDate | 2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.